Clinical CRO Solutions

Contract Research Organization (CRO)

Supporting Drug Development as a Contract Research Organization

The clinical phase of drug development refers to the stages of testing new drugs or therapies in human subjects and is divided into four main stages:

Phase I
Phase II
Phase III
Phase IV

This process can be a long and challenging. However, with the right vendor, you can see success from Phase I through Post-Approval. A Clinical CRO is integral to the success of clinical trials, providing expertise and support at every stage of the clinical phase to ensure the efficient and compliant development of new drugs.

As one of the largest Contract Research Organizations (CRO) in Japan, CMIC Group delivers comprehensive non-clinical, clinical, and regulatory consulting solutions, ensuring your product stays on the path to market from preclinical stages through Clinical Phase I-III and post-approval. With over three decades of industry expertise, our seasoned team excels in managing complex drug development processes, offering unparalleled global support across key regions including Japan, the USA, China, Australia, and more. As your CRO partner, we are dedicated to help you meet your goals.

Connect With Us

View All of CMIC's Clinical CRO Solutions

Regulatory Affairs
– Regulatory Affairs Consulting
– Regulatory Systems in Japan
– Regulatory Submission and Correspondence
– Medical Writing
Clinical Operations
Statistical Analysis
Pharmacovigilance
Data Management
Project Management
In-Country Clinical Caretake (ICCC)
Audit & Quality Assurance
Decentralized Clinical Trials (DCTs)
Patient Recruitment
Vendor Management

View CMIC’s Service Catalog >>

Our Edge in Clinical CRO Solutions

First Contract Research Organization (CRO) in Japan

Over 30 years ago, CMIC Group was founded as the first Contract Research Organization (CRO) in Japan. Now, our 1000+ CRAs and 150+ regulatory consultants in Japan and Asia Pacific support global clinical trials in various therapeutic areas.

Non-clinical Support Provides Seamless Precision

Through our compliance with various regulatory agencies, dedicated consulting team, coordinated analysis between Japan and US and global transfer capabilities, CMIC is able to move your drug candidate from preclinical research to Phase I-III clinical trials with seamless precision.

Expertise in Key Therapeutic Areas

With 720 protocols monitored in the past five years, our proficiency in cutting-edge areas like Oncology, CNS, Endocrinology & Metabolism, Cardiovascular, and Infectious Diseases ensures exceptional support and innovation in your clinical development journey.

Global Capabilities

With over 135 active clinical trial sites in China, Thailand, Hong Kong, Vietnam, Malaysia, Singapore, Australia, New Zealand, Indonesia, Taiwan, South Korea, the Philippines, CMIC Group has the capability to support our client’s clinical trials throughout Asia.

Client-Focused Approach

We understand the challenges of collaborating with vendors who lack effective communication, fail to prioritize your needs, and do not focus on your project. At CMIC Group, we place a high priority on our clients’ needs, working closely with you to thoroughly understand your goals and challenges. Our client-focused approach ensures that we provide personalized solutions tailored to your specific objectives, fostering a successful partnership and achieving positive outcomes.

What are your clinical research goals? What is the most significant challenge in your project? Let’s discuss how we can assist you.

Start The Discussion

What Our Clients Say

Working with CMIC Group as our Clinical CRO was crucial for our project. The team demonstrated their expertise and were quick to communicate throughout the process. We felt our specific needs were always at the forefront. Would work with CMIC again for future projects.

Clinical Operations Manager, Mid-Sized Biopharma